|
|
|
SOUTH AFRICA: Concerns raised about Nevirapine report
JOHANNESBURG, 13 February (PLUSNEWS) - A media report saying research had found that pregnant women using the anti-AIDS drug, Nevirapine, could develop resistance to future use of HIV/AIDS drugs, has raised concern in South Africa.
The findings were presented at the 11th Annual Retrovirus Conference, held recently in San Francisco in the US.
According to BuaNews, a local news service, Nevirapine was currently being used in the government's national programme for the prevention of mother-to-child transmission (PMTCT) of HIV at 18 pilot sites.
Health Minister Manto Tshabalala-Msimang responded by saying she had referred these concerns to the Medicines Control Council (MCC) for investigation as soon as possible, and would be advised of their findings.
[ENDS]
MORE NEWS BRIEFS
|
|
|
|
[Back] [Home Page]
Click to send any feedback, comments or questions you have about IRIN's Website or if you prefer you can send an Email to
The material contained on this Web site comes to you via IRIN, a UN humanitarian information unit, but may not necessarily reflect the views of the United Nations or its agencies. If you re-print, copy, archive or re-post any item on this site, please retain this credit and disclaimer. Quotations or extracts should include attribution to the original sources. All graphics and Images on this site may not be re-produced without the express permission of the original owner. All materials copyright © UN Office for the Coordination of Humanitarian Affairs 2004
|
